Jacqualyn A. Fouse, Director at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 16,782 shares at $22.99 ($386K) on 2024-01-09, disclosed to the SEC on 2024-01-09.
Scheduled sale ($386k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.99 | 8,391 | $193K | 50.0% |
| 2 | $22.99 | 8,391 | $193K | 50.0% |
| Total | $22.99 avg | 16,782 | $386K | 100% |
| Filing → |
| AGIO | SELL | 2024-01-24 | $464K | — | Filing → |
| AGIO | SELL | 2023-06-30 | $608K | — | Filing → |
| AGIO | BUY | 2019-11-15 | $1.2M | — | Filing → |